Skip to main content
Back
CON logo

Concentra Group Holdings Parent, Inc.

Data quality: 100%
CON
NYSE Healthcare Medical - Equipment & Services
$22.01
▲ $0.16 (0.73%)
Mkt Cap: 2.83B
Day Range
$21.57 $22.06
52-Week Range
$18.55 $24.69
Volume
632,446
50D / 200D Avg
$22.55 / $21.17
Prev Close
$21.85

Quick Summary

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (627 peers)

Metric Stock Sector Median
P/E 16.4 0.3
P/B 7.2 3.0
ROE % 51.7 3.7
Net Margin % 8.0 3.8
Rev Growth 5Y % 5.7 10.0
D/E 5.4 0.2

Analyst Price Target

Hold
$41.50 +88.6%
Low: $31.00 High: $52.00
Forward P/E
15.05
Forward EPS
$1.46
EPS Growth (est.)
+0.0%
Est. Revenue
2.31B

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2028 $1.87
$1.85 – $1.89
 2.61B 3
FY2027 $1.67
$1.63 – $1.70
 2.45B 4
FY2026 $1.46
$1.42 – $1.51
 2.31B 4

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-01-28 $0.23 $0.28 +23.5%
2025-11-06 $0.37 $0.39 +5.4%
2025-08-07 $0.37 $0.37 0.0%
2025-05-07 $0.31 $0.32 +3.2%
2025-03-03 $0.16 $0.17 +6.3%
2024-10-31 $0.36 $0.37 +2.8%
2024-08-27 $0.49 $0.50 +2.0%
2024-03-31 N/A $0.39 —

Dividend History

2 yr streak

Yield

0.01%

Payout Ratio

0.19%

Growth (3Y)

N/A

Growth (5Y)

N/A

Ex-Date Payment Date Amount Yield
Mar 12, 2026 Mar 19, 2026 $0.06 1.14%
Dec 02, 2025 Dec 09, 2025 $0.06 1.22%
Aug 21, 2025 Aug 28, 2025 $0.06 1.09%
May 20, 2025 May 29, 2025 $0.06 0.83%
Mar 18, 2025 Apr 01, 2025 $0.06 0.60%
Nov 13, 2024 Nov 22, 2024 $0.06 0.30%

Key Takeaways

Revenue grew 5.72% annually over 5 years — modest growth
ROE of 51.66% indicates high profitability
Debt/Equity of 5.35 — high leverage
Generating 197.06M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 8.13%
Cash machine — converts 114.04% of earnings into free cash flow

Growth

Revenue Growth (5Y)
5.72%
Revenue (1Y)13.85%
Earnings (1Y)3.76%
FCF Growth (3Y)9.29%

Quality

Return on Equity
51.66%
ROIC62.73%
Net Margin7.99%
Op. Margin96.50%

Safety

Debt / Equity
5.35
Current Ratio1.14
Interest Coverage19.10

Valuation

P/E Ratio
16.38
Forward P/E15.29
P/B Ratio7.20
EV/EBITDA2.33
Dividend Yield0.01%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 13.85% Revenue Growth (3Y) 8.49%
Earnings Growth (1Y) 3.76% Earnings Growth (3Y) -2.01%
Revenue Growth (5Y) 5.72% Earnings Growth (5Y) -4.63%
Profitability
Revenue (TTM) 2.16B Net Income (TTM) 172.80M
ROE 51.66% ROA 5.69%
Gross Margin 28.34% Operating Margin 96.50%
Net Margin 7.99% Free Cash Flow (TTM) 197.06M
ROIC 62.73% FCF Growth (3Y) 9.29%
Safety
Debt / Equity 5.35 Current Ratio 1.14
Interest Coverage 19.10
Dividends
Dividend Yield 0.01% Payout Ratio 0.19%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years 2 yrs
Valuation
P/E Ratio 16.38 Forward P/E 15.29
P/B Ratio 7.20 P/S Ratio 1.31
PEG Ratio 2.08 Forward PEG N/A
EV/EBITDA 2.33 Fwd EV/EBITDA 10.55
Forward P/S 1.22 Fwd Earnings Yield 6.54%
FCF Yield 6.96%
Market Cap 2.83B Enterprise Value 4.85B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2.16B 1.90B 1.84B 1.72B 1.73B
Net Income 172.80M 166.54M 179.95M 166.73M 208.88M
EPS (Diluted) 1.30 1.30 1.42 1.32 1.65
Gross Profit 613.09M 527.98M 512.43M 408.19M 427.98M
Operating Income 2.09B 304.76M 287.63M 258.22M 270.27M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 3.04B 2.52B 2.49B 2.30B
Total Liabilities 2.62B 2.22B 1.31B 1.30B
Shareholders' Equity 393.28M 275.67M 1.16B 973.32M
Total Debt 2.10B 1.95B 905.00M 1.04B
Cash & Equivalents 79.90M 183.26M 31.37M 37.66M
Current Assets 383.10M 437.21M 294.42M 284.63M
Current Liabilities 337.25M 307.19M 274.63M 279.63M